Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures

Oncology Letters

Volumn 10, Issue 3, 2015, Pages 1281-1286

  Kadletz, Lorenz ^a   Heiduschka, Gregor ^a   Domayer, Julian ^a   Schmid, Rainer ^a   Enzenhofer, Elisabeth ^a   Thurnher, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cell culture; Cisplatin; Head and neck squamous cell carcinoma; Irradiation; Multicellular spheroids

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CISPLATIN; GROWTH FACTOR; KI 67 ANTIGEN; SURVIVIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CELL PROLIFERATION; CYTOTOXICITY ASSAY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SPHEROID CELL;

EID: 84937419132     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3487     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Myers EN. Head and neck oncology-2010, part II. Otolaryngol Pol 64: 204-214, 2010.
3. Carvalho AL, Nishimoto IN, Califano JA and Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 114:806-816, 2005.
4. Kimlin LC, Casagrande G and Virador VM: In vitro three-dimensional (3D) models in cancer research: An update. Mol Carcinog52: 167-182, 2013.
5. Bokhari M, Carnachan RJ, Cameron NR and Przyborski SA: Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat 211:567-576, 2007.
6. Shain KH and Dalton WS: Cell adhesion is a key determinant in de novo multidrug resistance (MDR): New targets for the prevention of acquired MDR. Mol Cancer Ther 1: 69-78, 2001.
7. Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, et al: Relationships between drug activity in NCI preclinical invitro and invivo models and early clinical trials. Br J Cancer 84: 1424-1431, 2001.
8. Voskoglou-Nomikos T, Pater JL and Seymour L: Clinical predictive value of the invitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 9: 4227-4239, 2003.
9. Sutherland RM, McCredie JA and Inch WR: Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. JNatl Cancer Inst46: 113-120, 1971.
10. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, VasirJK, Jain TK, et al: 3-D tumor model for invitro evaluation of anticancer drugs. Mol Pharm5: 849-862, 2008.
11. Karlsson H, Fryknäs M, Larsson R and Nygren P: Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exp Cell Res318: 1577-1585, 2012.
12. Cordes N and Meineke V: Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells invitro. Strahlenther Onkol179: 337-344, 2003.
13. Khaitan D, Chandna S, Arya MB and Dwarakanath BS: Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. JTransl Med4: 12, 2006.
14. Lim Y, Keam B, Koh Y, Kim TM, Lee S-H, Hah JH, et al: Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol116: 55-60, 2013.
15. Vermorken JB and Specenier P: Optimal treatment for recurrent/metastatic head and neck cancer. Ann Oncol21 (Suppl7): vii252-vii261, 2010.
16. Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, et al: Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer119: 1349-1356, 2013.
17. Eke I, Schneider L, Förster C, Zips D, Kunz-SchughartLA and CordesN: EGFR/JIP-4/JNK2 signaling attenuates cetuximab-mediated radiosensitization of squamous cell carcinoma cells. Cancer Res 73: 297-306, 2013.
18. Colley HE, Hearnden V, Avila-Olias M, Cecchin D, Canton I, Madsen J, et al: Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D invitro evaluation. Mol Pharm 11: 1176-1188, 2014.
19. Eke I, Leonhardt F, Storch K, Hehlgans S and Cordes N: The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck. PLoS One4: e6434, 2009.
20. Kotowski U, Heiduschka G, Brunner M, Czembirek C, Eder-Czembirek C, Schmidt R, et al: Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane. Strahlenther Onkol187: 575-580, 2011.
21. Lill C, Schneider S, Pammer J, Loewe R, Gedlicka W, HoubenR, etal: Significant correlation of peptidyl-prolyl isomerase overexpression in Merkel cell carcinoma with overall survival of patients. Head Neck33: 1294-1300, 2011.
22. Xu W: CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis. Oncol Lett 6: 1289-1294, 2013.
23. Gildener-Leapman N, Ferris RL and Bauman JE: Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol49: 1089-1096, 2013.
24. Erjala K, Sundvall M, Junttila TT, Zhang N, Savisalo M, Mali P, etal: Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. Clin Cancer Res12: 4103-4111, 2006.
25. Ye Q, Cai W, Zheng Y, Evers BM and She QB: ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene 33: 1828-1839, 2014.
26. Desoize B, Gimonet D and Jardiller JC: Cell culture as spheroids: An approach to multicellular resistance. Anticancer Res18: 4147-4158, 1998.
27. Elliott NT and Yuan F: A review of three-dimensional invitro tissue models for drug discovery and transport studies. J Pharm Sci100: 59-74, 2011.
28. Lee GY, Kenny PA, Lee EH and Bissell MJ: Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods4: 359-365, 2007.
29. Ingargiola M, Runge R, Heldt J-M, Freudenberg R, Steinbach J, Cordes N, et al: Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Int J Cancer135: 968-980, 2014.
30. Rasanen K, Sriswasdi S, Valiga A, Tang H-Y, Zhang G, PeregoM, et al: Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol Cell Proteomics12: 3778-3792, 2013.
31. Yan M, Yang X, Wang L, Clark D, Zuo H, Ye D, et al: Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol Cell Proteomics12: 3271-3284, 2013.
32. Waldron NN, Barsky SH, Dougherty PR and Vallera DA: A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma. Target Oncol 9: 239-249, 2014.
33. Yang W-H, Lan H-Y, Tai S-K and Yang M-H: Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells. Biochem Biophys Res Commun433: 24-30, 2013.
34. Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MYP, Lin BR, etal: Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 73: 4147-4157, 2013.
35. Dennis M, Wang G, Luo J, Lin Y, Dohadwala M, AbemayorE, etal: Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg147: 726-732, 2012.
36. Duarte S, Loubat A, Momier D, Topi M, Faneca H, PedrosodeLimaMC, et al: Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect. Oncol Rep28: 1057-1062, 2012.
37. Chen Y-S, Wu M-J, Huang C-Y, Lin S-C, Chuang T-H, Yu C-C and Lo JF: CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One6: e28053, 2011.
38. Lim YC, Oh S-Y, Cha YY, Kim S-H, Jin X, Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol47: 83-91, 2011.
39. Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, et al: Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res70: 9969-9978, 2010.
40. Kross KW, Heimdal JH, Olsnes C, Olofsson J and AarstadHJ: Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis. Scand J Immunol67: 392-399, 2008.
41. Harper LJ, Piper K, Common J, Fortune F and MackenzieIC: Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med36: 594-603, 2007.
42. Olsnes C, Heimdal J-H, Kross KW, Olofsson J and AarstadHJ: Viable head and neck tumor spheroids stimulate invitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. Eur Arch Otorhinolaryngol262: 953-960, 2005.
43. Kross KW, Heimdal J-H, Olsnes C, Olofsson J and AarstadHJ: Head and neck squamous cell carcinoma spheroid-and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Otolaryngol125: 1097-1104, 2005.
44. Heimdal JH, Olsnes C, Olofsson J and Aarstad HJ: Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids. Cancer Immunol Immunother50: 300-306, 2001
45. Heimdal JH, Aarstad HJ, Olsnes C and Olofsson J: Human autologous monocytes and monocyte-derived macrophages in co-culture with carcinoma F-spheroids secrete IL-6 by a non-CD14-dependent pathway. Scand J Immunol53: 162-170, 2001.
46. Heimdal J, Aarstad HJ and Olofsson J: Monocytes secrete interleukin-6 when co-cultured invitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients. Scand J Immunol51: 271-278, 2000.
47. Fayad W, Brnjic S, Berglind D, Blixt S, Shoshan MC, BerndtssonM, etal: Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model. Int J Cancer125: 2450-2455, 2009.
48. Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger PØ, Slotman B and Bjerkvig R: Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res23: 1461-1466, 2003.
49. Shweiki D, Neeman M, Itin A and Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 92: 768-772, 1995.
50. Sivaraj KK, Takefuji M, Schmidt I, Adams RH, Offermanns S and Wettschureck N: G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell25: 427-434, 2013.
51. Töyli M, Rosberg-Kulha L, Capra J, Vuoristo J and EskelinenS: Different responses in transformation of MDCK cells in 2D and 3D culture by v-Src as revealed by microarray techniques, RT-PCR and functional assays. Lab Invest90: 915-928, 2010.